Fulcrum Therapeutics, Inc. (FULC)

12.06 +0.27 (+2.29%) USD  |  NASDAQ  |  Dec 24, 12:59
12.00 -0.06 (-0.46%) After-Hours: 13:59
More

Fulcrum Therapeutics SG&A Expense (TTM): 29.10M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for FULC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. 180.37M
Biogen, Inc. 2.431B
CorMedix, Inc. 75.56M
Apellis Pharmaceuticals, Inc. 524.64M
NovaBay Pharmaceuticals, Inc. 8.584M